Case Number: 5-110-001, Year Published: 2010, Revision Date: June 11, 2014
HBS Number: KEL439
Financial Analysis, Investment Decisions, Marketing Strategy, Clinical Trials, Biotechnology, Medical Devices
Executives at biotechnology firm Genzyme are debating funding a clinical trial for a new version of a medical device called Synvisc. The trial is expensive and the odds of success are not high, but the upside is substantial. The case presents a common business question: invest or not? The case forces students to think about customer insights, wrestle with a number of complex issues, and evaluate the financials of the decision.
The case is ideal for teaching financial analysis and decision making. It can also be used to teach marketing, new product strategy, and healthcare industry management.
Return to Search Results
